Immune dysfunction in multiple myeloma. Reduced natural killer cell activity and increased levels of soluble interleukin-2 receptors-Reference-Cited by-同舟云学术

Immune dysfunction in multiple myeloma. Reduced natural killer cell activity and increased levels of soluble interleukin-2 receptors

Published:1991-01 Issue:1-6 Volume:99 Page:340-346
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:

Author:

NIELSEN HENRIK,NIELSEN HANS J.,TVEDE NIELS,KLARLUND KIM,MANSA BENDT,MOESGAARD FLEMMING,DRIVSHOLM AAGE

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1699-0463.1991.tb05159.x/fullpdf

Reference25 articles.

1. A study of Russell bodies in human monoclonal plasma cells by means of immunofluorescence and electron microscopy;Blom;Acta path. microbiol. immunol. scand. Sect A

2. A study of certain functional parameters of monocytes from patients with multiple myeloma: comparison with monocytes from healthy individuals;Blom;Scand. J. Haematol.,1984

3. Characteristics of Multiple Myeloma as an Immunodeficiency Disease

4. Production of interleukin 2 in multiple myeloma;Commes;Clin. exp. Immunol.,1986

5. Defective monocyte chemotactic responsiveness in patients with multiple myeloma and benign monoclonal gammapathy;Dammacco;Clin. exp. Immunol.,1982

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4–1BB: A preclinical study in multiple myeloma;Biomedicine & Pharmacotherapy;2024-07

2. Harnessing Unconventional T Cells and Innate Lymphoid Cells to Prevent and Treat Hematological Malignancies: Prospects for New Immunotherapy;Biomolecules;2022-05-27

3. Harnessing natural killer cells for the treatment of multiple myeloma;Seminars in Oncology;2022-02

4. Therapeutic Potential of Innate Lymphoid Cells for Multiple Myeloma Therapy;Cancers;2021-09-26

5. Functional expression of aryl hydrocarbon receptor as a potential novel therapeutic target in human multiple myeloma;Leukemia & Lymphoma;2021-07-07